Hillrom to acquire Bardy Diagnostics for $375M

Hillrom has reached a definitive agreement to acquire Bardy Diagnostics, a provider of ambulatory cardiac monitoring technologies, for $375 million in cash plus potential milestone payments. The deal includes net operating losses valued at over $20 million.

“This acquisition provides Hillrom with a highly strategic and differentiated diagnostic cardiology platform aligned with our vision of Advancing Connected Care™.”prnewswire.com

• 1 source
• prnewswire.comHillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.HillromJan 19, 2021

Summarized from public sources; check the original articles before acting on it.